Jeffrey Behrens
Fondatore presso Telluride Group
Profilo
Jeffrey S.
Behrens is the founder of Telluride Group (1995) and LabShares Newton LLC (2018), where he held the title of Director.
He is currently the President, Chief Executive Officer & Treasurer at GelMEDIX, Inc. and a Director at Savran Technologies, Inc. In the past, he held positions such as President, Chief Executive Officer & Director at Siamab Therapeutics, Inc., Director-Strategic Alliances at Alnylam Pharmaceuticals, Inc., Senior Director-Business Development & Operations at Edimer Pharmaceuticals, Inc., Head-Business Operations at Biogen, Inc., Principal at Escoublac, Inc., and Member at Launchpad Venture Group LLC.
Posizioni attive di Jeffrey Behrens
| Società | Posizione | Inizio |
|---|---|---|
Telluride Group
 Telluride Group Information Technology ServicesTechnology Services Part of MARS Acquisition Corp., Telluride Group is a company that provides managed information technology (IT) services. The company is based in Newton, MA. The company was founded by Jeffrey S. Behrens. Telluride Group was acquired by mindSHIFT Technologies, Inc. on November 12, 2003. | Fondatore | 02/06/2010 |
Labshares Newton LLC
 Labshares Newton LLC Real Estate DevelopmentFinance Labshares Newton LLC engages in the provision of office space and laboratory incubator for biotechnology and life science start-ups. It also offers support services and amenities. The company was founded by Jeff Behrens and Jenna Stein in 2018 and is headquartered in Newton, MA. | Fondatore | 01/01/2018 |
GelMEDIX, Inc.
 GelMEDIX, Inc. Miscellaneous Commercial ServicesCommercial Services GelMEDIX, Inc. operates as a biotechnology technology. The company is headquartered in Newton, MA. | Amministratore Delegato | - |
Savran Technologies, Inc.
 Savran Technologies, Inc. BiotechnologyHealth Technology Savran Technologies, Inc. provide and develops a technology to isolate ultra-rare cells from blood. The company was founded by Cagri Savran in 2018 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Jeffrey Behrens
| Società | Posizione | Fine |
|---|---|---|
Escoublac, Inc.
 Escoublac, Inc. BiotechnologyHealth Technology Escoublac, Inc. offers treatment for obesity and related disorders. It aims to transform the discovery into new therapies for metabolic disorders and related conditions such as obesity and type II diabetes. The company was founded in 2007 by Gerard Karsenty and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 31/08/2012 |
Siamab Therapeutics, Inc.
 Siamab Therapeutics, Inc. Medical SpecialtiesHealth Technology Siamab Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of novel cancer immunotherapies. Its platform enables the rapid discovery of therapeutic antibodies that bind with unprecedented specificity and affinity to the novel class of carbohydrate antigens present on cancer cells called tumor-associated carbohydrate antigens (TACAs). The company was founded by Ajit Varki and Nissi Varki in 2006 and is headquartered in Newton, MA. | Amministratore Delegato | - |
| BIOGEN INC. | Corporate Officer/Principal | - |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Edimer Pharmaceuticals, Inc.
 Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edimer Pharmaceuticals, Inc. provides biopharmaceutical products for improving the health and quality of life of families living with XLHED. It has developed EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), which is a rare orphan disease that causes symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. The company was founded by Pascal Schneider and Olivier Gaide in 2009 and is headquartered in Cambridge, MA. | Direttore operativo | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 8 |
|---|---|
Siamab Therapeutics, Inc.
Siamab Therapeutics, Inc. Medical SpecialtiesHealth Technology Siamab Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of novel cancer immunotherapies. Its platform enables the rapid discovery of therapeutic antibodies that bind with unprecedented specificity and affinity to the novel class of carbohydrate antigens present on cancer cells called tumor-associated carbohydrate antigens (TACAs). The company was founded by Ajit Varki and Nissi Varki in 2006 and is headquartered in Newton, MA. | Health Technology |
Escoublac, Inc.
Escoublac, Inc. BiotechnologyHealth Technology Escoublac, Inc. offers treatment for obesity and related disorders. It aims to transform the discovery into new therapies for metabolic disorders and related conditions such as obesity and type II diabetes. The company was founded in 2007 by Gerard Karsenty and is headquartered in Cambridge, MA. | Health Technology |
Telluride Group
Telluride Group Information Technology ServicesTechnology Services Part of MARS Acquisition Corp., Telluride Group is a company that provides managed information technology (IT) services. The company is based in Newton, MA. The company was founded by Jeffrey S. Behrens. Telluride Group was acquired by mindSHIFT Technologies, Inc. on November 12, 2003. | Technology Services |
Launchpad Venture Group LLC
 Launchpad Venture Group LLC Investment ManagersFinance Launchpad Venture Group LLC (Launchpad Venture Group) is a venture capital firm founded in 2001 by Rick Lucash. The firm is headquartered in Newton, Massachusetts. | Finance |
Edimer Pharmaceuticals, Inc.
Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edimer Pharmaceuticals, Inc. provides biopharmaceutical products for improving the health and quality of life of families living with XLHED. It has developed EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), which is a rare orphan disease that causes symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. The company was founded by Pascal Schneider and Olivier Gaide in 2009 and is headquartered in Cambridge, MA. | Health Technology |
Savran Technologies, Inc.
Savran Technologies, Inc. BiotechnologyHealth Technology Savran Technologies, Inc. provide and develops a technology to isolate ultra-rare cells from blood. The company was founded by Cagri Savran in 2018 and is headquartered in Cambridge, MA. | Health Technology |
Labshares Newton LLC
Labshares Newton LLC Real Estate DevelopmentFinance Labshares Newton LLC engages in the provision of office space and laboratory incubator for biotechnology and life science start-ups. It also offers support services and amenities. The company was founded by Jeff Behrens and Jenna Stein in 2018 and is headquartered in Newton, MA. | Finance |
GelMEDIX, Inc.
GelMEDIX, Inc. Miscellaneous Commercial ServicesCommercial Services GelMEDIX, Inc. operates as a biotechnology technology. The company is headquartered in Newton, MA. | Commercial Services |
- Borsa valori
- Insiders
- Jeffrey Behrens
